SCHEMBL6709898

SCHEMBL6709898

COCC(C)Oc1cccc2cc(C(=O)Nc3ccc(Br)cc3-c3noc(=O)[nH]3)n(C)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.36
BACE1 P56817 5/20 0.33
BRPF1 P55201 2/20 0.32
MAPT P10636 3/20 0.31
LMNA P02545 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GRM5 P41594 1/20 0.31
HPGD P15428 2/20 0.31
RAB9A P51151 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
ABL1 P00519 1/20 0.31
NPC1 O15118 1/20 0.31
HTT P42858 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
GCK P35557 1/20 0.31
LCK P06239 1/20 0.31
HIF1A Q16665 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6919319 0.98 BRPF1 (0.35) GRIK1BACE1BRPF1MAPTLMNA
SCHEMBL6711732 0.91 GRIK1 (0.38) GRIK1MAPTABL1RXFP1
SCHEMBL6710021 0.91 GRIK1 (0.39) GRIK1BACE1BRPF1MAPTLMNA
SCHEMBL6709918 0.89 GRIK1 (0.38) GRIK1BACE1BRPF1MAPTLMNA
SCHEMBL6708965 0.89 GCK (0.32) GCKLCK
SCHEMBL6712425 0.86 TP53 (0.38) GRIK1MAPTLMNAGRM5RAB9A
SCHEMBL6710035 0.85 GRIK1 (0.36) GRIK1BACE1MAPTLMNAKDM4E
SCHEMBL6710032 0.85 GRIK1 (0.36) GRIK1BACE1MAPTLMNAKDM4E
SCHEMBL6713324 0.85 NPSR1 (0.35) BACE1BRPF1MAPTLMNAKDM4E
SCHEMBL6713722 0.85 NR2E1 (0.35) GRIK1BACE1MAPTLMNAGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885BACE1 3406/4885BRPF1 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.